STAT

FEBRUARY 12, 2024

A new study has shown that people vaccinated against Ebola who still developed the disease had a substantially lower risk of dying than people who were not vaccinated, even if they received the vaccine when they were already infected with the virus. It confirms just how major an advancement the Ebola vaccine remains; the study is the first to show that in addition to preventing infections, the vaccine can save some people who are already sick with the often fatal disease.

Vaccines 363

Vaccines 363

PharmaVoice

FEBRUARY 12, 2024

Commissioner Dr. Robert Califf signals how the FDA will consider AI in drug development and how the agency may use the emerging technology in the future.

Drug Development 148

Drug Development 148

STAT

FEBRUARY 12, 2024

Super Bowl ads are a show within the show, an opportunity for brands and advertising creatives to put their work in front of more than 100 million viewers. And while the occasion is most closely associated with ads for beer, cars, and soft drinks, pharma giant Pfizer dished out millions of dollars for its own message: “Here’s to science.

Hospitals 351

Hospitals 351

PharmaVoice

FEBRUARY 12, 2024

A new use for an existing ultrasound technology is seeing early success in getting medications past the blood-brain barrier.

148

148

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

FEBRUARY 12, 2024

A growing body of data show that South Asians are at greater risk of developing heart disease than white people, and they tend to get complications at younger ages, but it’s not been fully clear what explains this disparity. A new study suggests one potential reason is that South Asians have a decreased ability to repair blood vessels that get injured from cardiovascular problems.

348

348

Pharmaceutical Technology

FEBRUARY 12, 2024

The UK MHRA has granted approval for a variation in licence of Pfizer-BioNTech’s Comirnaty XBB.1.5 vaccine targeting Omicron variant.

Vaccines 142

Vaccines 142

The Pharmacist

FEBRUARY 12, 2024

The London School of Hygiene and Tropical Medicine (LSHTM) has been awarded a £2.4m contract by the National Institute for Health and Care Research (NIHR) to monitor the Pharmacy First service in England. The LSHTM research team will work in partnership with experts at the UK Health Security Agency and the Oxford, Manchester and Nottingham […] The post Pharmacy First AMR impact under spotlight in £2.4m research project appeared first on The Pharmacist.

119

119

STAT

FEBRUARY 12, 2024

You’re reading the web version of Health Care Inc.,  STAT’s weekly newsletter  following the flow of money in medicine.  Sign up  to get it in your inbox every Monday.  The FTC doubles down on private equity and Big Physician Dominant physician groups don’t command the same attention as, say, Big Tech firms with national omnipresence like Google and Facebook.

Hospitals 323

Hospitals 323

pharmaphorum

FEBRUARY 12, 2024

Investing in women's health research and funding is not a charity, but a priority. Discover the importance of allocating resources and supporting initiatives that promote women's health and well-being.

112

112

STAT

FEBRUARY 12, 2024

Lina Khan’s Federal Trade Commission is eager to make Big Physician a lot smaller. Last September, the FTC sued private equity firm Welsh, Carson, Anderson & Stowe and U.S. Anesthesia Partners, alleging the two parties conspired to create monopolies for anesthesia services. Both Welsh Carson and USAP have tried to get the case thrown out , but the FTC recently doubled down.

314

314

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

The Pharmacist

FEBRUARY 12, 2024

NHS England (NHSE) is launching 12 ‘demonstrator sites’ to test ‘new and innovative’ models of vaccination delivery, it has said. Slides from a webinar aimed at general practitioners last week revealed that the sites would be launched in March, and would explore ‘how more flexible approaches to ICB [Integrated Care Board] commissioning can enable ways […] The post NHSE pilot to test new models of vaccination delivery appeared first on The Pharmacist.

Vaccines 108

Vaccines 108

STAT

FEBRUARY 12, 2024

UnitedHealth Group’s Optum has bought an untold number of physician practices over the years. It either owns or is affiliated with over 90,000 providers — almost 10% of all U.S. physicians. That’s mostly happened quietly. But a new Optum purchase in Oregon is getting outsized scrutiny from state regulators — a trend experts say is actually on the rise.

Hospitals 293

Hospitals 293

Pharma Times

FEBRUARY 12, 2024

The phase 1/2 Mobilize trial is evaluating the safety and efficacy of mRNA-4359

141

141

STAT

FEBRUARY 12, 2024

Gilead Sciences said Monday it will acquire CymaBay Therapeutics for $4.3 billion, adding a new treatment for a liver disease that is on track for approval later this year. The deal values CymaBay at $32.50 per share, 27% higher than the stock’s close last Friday. That’s a relatively small takeout premium, but CymaBay shares have doubled in value since last fall on growing investor confidence in the company’s lead drug and speculation that the company could be acquired.

283

283

pharmaphorum

FEBRUARY 12, 2024

Study finds that monitoring of rheumatoid arthritis patients with an Apple Watch and iPhone and AI algorithm improves on standard practices.

114

114

STAT

FEBRUARY 12, 2024

On Feb. 5, Buckingham Palace shared the news that King Charles had started treatment for cancer. Although the official statement did not include the particular type of cancer, it closed by noting that, “His Majesty has chosen to share his diagnosis to prevent speculation and in the hope it may assist public understanding for all those around the world who are affected by cancer.

267

267

Express Pharma

FEBRUARY 12, 2024

Aparna Pharmaceuticals announced that its manufacturing facility, Aparna Organics, located in Pydibhimavaram, Srikakulalam, Andhra Pradesh, India has received VAI classification from the United States Food and Drug Administration (USFDA). The USFDA audited the facility during the month of September 2023. Rakesh Reddy, MD, Aparna Pharmaceuticals said, “This clearance is a testament to our team’s relentless pursuit of excellence.

97

97

STAT

FEBRUARY 12, 2024

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Hello! Hope your team of choice was victorious in last night’s sports ball match. Today, we talk about psychedelics, obesity, and production issues with generic drugs. We also discuss the ongoing issues of scientific misconduct that are springing up left and right in academia, and how universities are scrambling to keep up.

Drug Pricing 266

Drug Pricing Drug Development 266

pharmaphorum

FEBRUARY 12, 2024

Gilead Sciences has beefed up its pipeline with an agreement to buy CymaBay Therapeutics and its seladelpar drug for primary biliary cholangitis (PBC) for $4.

102

102

STAT

FEBRUARY 12, 2024

While staffing crises at hospitals continue to make headlines, dental care — too often overlooked and treated as separate from medical — is also experiencing a significant workforce challenge. In my role leading dental at Sun Life U.S., which includes DentaQuest, the nation’s largest Medicaid dental benefits organization, I know full well that you cannot be healthy without a healthy mouth.

Diabetes 250

Diabetes Hospitals 250

Pharma Times

FEBRUARY 12, 2024

The chip removes cells, which could become tumours, before they are implanted in a patient

126

126

STAT

FEBRUARY 12, 2024

Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because that oh-so-familiar routine of online meetings, phone calls, and deadlines has returned. But what can you do? The world, such as it is, continues to spin at a brisk pace. So time to give it a nudge in a better direction with a cup or three of stimulation.

Diabetes 200

Diabetes Vaccines Communication Hospitals 200

Pharma Times

FEBRUARY 12, 2024

The platform delivers digitalised patient data to improve clinical trials and development

126

126

pharmaphorum

FEBRUARY 12, 2024

GSK’s antisense-based drug for chronic hepatitis B, bepirovirsen, will get a rapid six-month review from the FDA when it is filed for approval

105

105

Pharma Times

FEBRUARY 12, 2024

The projects will focus on healthcare in LMICs in the event of extreme weather

127

127

pharmaphorum

FEBRUARY 12, 2024

Biotech giant CSL has seen almost 5% wiped off the value of its shares after one of its most anticipated pipeline products failed a phase 3 trial in heart attack patients

94

94

World Pharma News

FEBRUARY 12, 2024

An experimental mRNA vaccine against human cytomegalovirus (CMV), a common virus that can infect babies during pregnancy, elicited some of the most promising immune responses to date of any CMV vaccine candidate, according to a study by Weill Cornell Medicine investigators.

Vaccines 90

Vaccines Immunity Immunization 90

pharmaphorum

FEBRUARY 12, 2024

Changing Faces: Agency, consultancy, and investor hires from January 2024 highlights the recent hires and movements in prominent companies such as Permira, Cuttsy+Cuttsy, SV Health Investors, and Cure Ventures. Stay updated with the latest talent appointments in the industry.

89

89

BioPharma Dive

FEBRUARY 12, 2024

The proposed acquisition is a bet on CymaBay’s drug seladelpar, which is now under FDA review in a chronic liver disease called primary biliary cholangitis.

117

117

European Pharmaceutical Review

FEBRUARY 12, 2024

Researchers based in France have demonstrated a robust online Raman monitoring model for bioreactors, which combines Raman spectroscopy and machine learning (ML). In the study, the fermentation of alcohol by Saccharomyces cerevisiae ( S. cerevisiae) was used as a benchmark bioprocess. The method was validated across numerous batches and a fed-batch bioreactor.

Compounding 80

Compounding 80

Outsourcing Pharma

FEBRUARY 12, 2024

Verisense Health, Inc., is now able to generate richer patient insights after adopting Datavantâs data connectivity platform.

105

105

Pharmaceutical Technology

FEBRUARY 12, 2024

The humanised monoclonal antibody DISC-3405 is under investigation in a Phase I clinical trial, with data expected this year.

95

95

BioPharma Dive

FEBRUARY 12, 2024

Explore how companies are optimizing efficiency, enhancing customer experiences and embracing AI.

102

102

Big Molecule Watch

FEBRUARY 12, 2024

Today, the district court for the Western District of Texas granted the government’s motion to dismiss the lawsuit brought by PhRMA and other organizations challenging the Drug Price Negotiation Program of the Inflation Reduction Act. The lawsuit was brought by three Plaintiffs: PhRMA, the Global Colon Cancer Association, and the National Infusion Center Association (“NICA”).

Drug Pricing 67

Drug Pricing 67

Express Pharma

FEBRUARY 12, 2024

Fredun Pharmaceuticals announced significant milestones in its business expansion and product development initiatives. It has received orders from Southeast Asian (SEA) countries, amounting to Rs 28 crores. These orders demonstrate the company’s growing presence in the international markets and hold substantial potential to scale up over the years.

64

64